← Back to Search

Coaching for Performance Improvement in Opioid Use Disorder

N/A
Recruiting
Led By Charles Neighbors, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed from commencement of the trial in year 1 of the study to the conclusion of the trial in year 4 of the study.
Awards & highlights

Study Summary

This trial will help to increase the use of medicines for opioid use disorders, retain clients longer in care, and help more people move into successful recovery.

Who is the study for?
This trial is for substance use disorder clinics near New York City and the Capital Region with at least 50 clients yearly. It includes staff and patients on Medicaid, not co-insured with Medicare, from these clinics. Clinics with fewer than 50 annual clients are excluded.Check my eligibility
What is being tested?
The study tests a clinic-level intervention called Metrics-driven quality improvement (MDQI). It involves training in data management, patient-centered care for opioid disorders, and electronic tools for decision making and monitoring patient progress.See study design
What are the potential side effects?
Since this trial focuses on coaching and training methods rather than medications or medical procedures, traditional side effects are not applicable. However, there may be indirect impacts on clinic operations or patient experiences.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed from commencement of the trial in year 1 of the study to the conclusion of the trial in year 4 of the study.
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed from commencement of the trial in year 1 of the study to the conclusion of the trial in year 4 of the study. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Health Status
Change in Incidence of Overdoses
Change in Incidence of Substance Use-Related Hepatitis C Infection
+4 more
Secondary outcome measures
Change in clinic level-rates of clients identified as homeless
Change in clinic-level rates of clients with Severe OUD
Change in clinic-rates of clients with co-existing psychiatric disorder as indicated in state administrative admission data
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Metrics-driven quality improvement (MDQI) interventionExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention

Find a Location

Who is running the clinical trial?

New York State Office of Addiction Services and SupportsUNKNOWN
UConn HealthOTHER
211 Previous Clinical Trials
52,671 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,468 Previous Clinical Trials
2,611,398 Total Patients Enrolled

Media Library

Metrics-driven quality improvement (MDQI) Clinical Trial Eligibility Overview. Trial Name: NCT04632238 — N/A
Opioid Use Disorder Research Study Groups: Control, Metrics-driven quality improvement (MDQI) intervention
Opioid Use Disorder Clinical Trial 2023: Metrics-driven quality improvement (MDQI) Highlights & Side Effects. Trial Name: NCT04632238 — N/A
Metrics-driven quality improvement (MDQI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04632238 — N/A
Opioid Use Disorder Patient Testimony for trial: Trial Name: NCT04632238 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment currently underway for this experiment?

"As per the details provided on clinicaltrials.gov, this investigation is presently enlisting participants. This research was initially publicized on July 1st 2020 and updated recently on May 6th 2022."

Answered by AI

How many volunteers are taking part in this clinical experiment?

"Affirmative. The information on clinicaltrials.gov proves that the experiment is presently recruiting participants and seeking a total of 7950 people from 4 separate medical centres. It was first posted on July 1st 2020, with its most recent edit being made on May 6th 2022."

Answered by AI

Who else is applying?

What state do they live in?
New York
What site did they apply to?
Samaritan Daytop Village Harlem - Outpatient Program
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I need to do something to help me.
PatientReceived 2+ prior treatments
~338 spots leftby Jun 2024